Target : International, multicenter trial comparing the use of enoxaparine IV versus standard IV heparine in patients presenting acute myocardial infarction to be treated with primary percutaneous coronary intervention.

Trial date : 2008

Number of patients : 910

Source of funding : Public (APHP) et private (Sanofi-Aventis)

Centers participating : 73 centers in 4 countries (51 french, 13 german, 6 austrian and 3 american centers)

N°NCT : NCT00718471

STATUT

Publication in The Lancet august 2011

Publication in The American Journal of Cardiology – june 2013

Publication in The American Journal of Cardiology – november 2013

Publication in The American Heart Journal – october 2015

Publication in Angiology – february 2016